This site uses cookies, including third-party cookies, that help us to provide and improve our services. Read More

Conjugated Estrogen Market

Conjugated Estrogen Market

Conjugated Estrogen Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028

Conjugated Estrogen Market

Market Overview

Conjugated estrogen is an active pharmaceutical ingredient that contains a mixture of steroidal and non-steroidal components that are obtained from pregnant mares’ urine. Conjugated estrogen is used as an external source and is prescribed as a replacement of female natural hormones. Estrogen has many well-known effects on the tissues of the body. It causes the growth of the inner lining of uterus, secretion of cervix, development & growth of female sexual organs and maintains the sexual characteristics of females, such as hair growth of underarm and pubic area and countering of body and bone.

Menopause is diagnosed when a woman has not had menses for one year. Due to the low production of estrogen in the body, about 85% of women have symptoms such as hot flushes, bone loss, vaginal dryness and shrinkage of tissues. For these symptoms, menopause hormone treatment therapy is the most effective treatment. Conjugated estrogen helps menopausal women treat symptoms such as shrinkage of vaginal tissue, vaginal dryness, hot flashes, bone loss and painful intercourse.

However, there are many side effects of conjugated estrogen such as breast swelling, abdominal pain, vaginal bleeding, nausea and mood swings. Patients with heart & kidney diseases should be careful while taking conjugated estrogen as it cause retention of salt & water in the body. Also, a high dose of conjugated estrogen can cause clotting of blood in legs and lungs. Hence, smokers have a high risk of clots and are recommended to quit smoking if they are prescribed conjugated estrogen. Before taking conjugated estrogen, its side effects, dosage, drug interactions, risks and storage should be reviewed properly.

Conjugated Estrogen Market: Drivers and Restraints

Menopause is a natural and normal process in women, which occurs due to aging and lowers the function of ovaries and lowers the levels of estrogen and other hormones in the body. The growing prevalence of the female geriatric population and women with menopause is the major factor driving the growth of the conjugated estrogens market over the forecast period. However, limited awareness and negligence about women healthcare services in developing nations and related side effects among women due to menopause hormone treatment therapy are restraining the revenue growth of the global conjugated estrogen market.

Know More Details About the Report

Conjugated Estrogen Market: Overview

The global market for conjugated estrogen is expected to grow at a high rate over the forecast period. Rising population of ageing women with menopause and the rising demand for treatment-related menopause are driving the growth of the conjugated estrogen market. Women with menopause are at a high risk of cardiovascular disease and osteoporosis due to the low production of estrogen in the body. Decreased production of estrogen causes loss of bone density, which in turn causes osteoporosis and fractures in women.

Conjugated estrogen is well-known as an external source and is prescribed as a replacement for female natural hormones. It can be helpful to maintain and balance women health and deal with the symptoms caused by menopause. However, conjugated estrogen is not prescribed to women who have undergone surgical removal of the uterus as estrogen promote abnormal thickening of the lining of the uterus, which can increase the risk of endometrial cancer. But the combination of progestin with estrogen can prevent endometrial cancer. Also, there is a high risk of memory loss and disturbance of thinking process among women over age 65 treated with conjugated estrogen. These factors can retrain the growth of the conjugated estrogen market.

Conjugated Estrogen Market: Regional Outlook

On the basis of geography, the global conjugated estrogen market has been segmented into viz. North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East & Africa (MEA). North America is expected to be the dominant market in the global conjugated estrogen market due to growing prevalence of the geriatric female population with menopause, initiatives towards increasing female health awareness and health coverage. Conjugated estrogen is specifically approved in the United States and Canada for menopause-related problems.

Europe is expected to register the second largest share in the global conjugated estrogen market throughout the forecast period, owing to the increasing awareness regarding female healthcare. The conjugated estrogen market in Asia Pacific excluding Japan is expected to grow at a high CAGR due to large population growth and increasing aging population of women and large presence of local players.

Avail customized purchase options for your needs

Conjugated Estrogen Market: Market Participants

Some of the key players in the global conjugated estrogen market include

  • Pfizer Inc.
  • Teva Pharmaceuticals USA, Inc.
  • Xi'an sgonek biological Technology Co., Ltd.
  • Teva Branded Pharm
  • Others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

An Adaptive Approach to Modern-day Research Needs

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Western Europe (Germany, Italy, U.K., Spain, France, Nordic countries, BENELUX)
  • Eastern Europe (Russia, Poland, Rest of Eastern Europe)
  • Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, Rest Of MEA)

Report Highlights: 

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

Have a report related query? Speak to us directly

Conjugated Estrogen Market: Segmentation

The global conjugated estrogen market can be segmented on the basis of form, route of administration, end user and geography.

Based on form, the global conjugated estrogen market has been segmented as:

  • Tablets
  • Creams
  • Powder
  • Vials

Based on route of administration, the global conjugated estrogen market has been segmented as:

  • Oral
  • Topical
  • Injection

Based on end user, the global conjugated estrogen market has been segmented as:

  • Hospitals
  • Obstetrics & Gynecology Clinics
  • Others

Based on geography, the global conjugated estrogen market has been segmented as:

  • North America
  • Latin America
  • Europe
  • Asia-Pacific excluding Japan (APEJ)
  • Japan
  • Middle East & Africa (MEA)

Need an Exclusive Report for your Unique Requirement?

Talk Show:

The Rise of Intelligent Packaging

Personalized, Connected and Sustainable

November 18, 2021 11:00-11:45 AM PST (USA & Canada)
This is a LIVE session
Future Market Insights MarketNgage Spring

- Our Clients -

Report Client

- Evaluate How Fact.MR's Report Can Help. -

Is the market research conducted by Fact.MR?

Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.

What research methodology is followed by Fact.MR?

Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.

What are the sources of secondary research?

Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.

Who are the respondents for primary research?

Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.

Is a sample of this report available for evaluation?

Yes, you can request a sample, and it will be sent to you through an email.